P.129 One-year data from ENDEAVOR, a phase 1b trial of delandistrogene moxeparvovec in boys with DMD
| Autor: | Zaidman, C., Proud, C., McDonald, C., Mason, S., Guridi, M., Wang, S., Reid, C., Darton, E., Wandel, C., Lewis, S., Malhotra, J., Griffin, D., Potter, R., Rodino-Klapac, L., Mendell, J. |
|---|---|
| Zdroj: | In Neuromuscular Disorders October 2022 32 Supplement 1:S101-S101 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect